Spurred by the horrendous events of September 11, 2001, the Food and Drug Administration has worked to prevent and mitigate the effects of bioterrorism, and to be prepared if a bioterrorist attack should ever occur.
"We've made very important contributions toward protecting the nation against its enemies," says Boris Lushniak, MD, MPH, FDA's Assistant Commissioner for Counterterrorism Policy.
Bioterrorism refers to a deliberate release of viruses, bacteria, fungi or toxins from living organisms to cause illness or death in people, animals, or plants. Harmful agents can be spread through the air, water, or in our food.
In the event that a biological agent is released in the United States, FDA would work closely with federal, state, and local authorities to investigate the problem and get contaminated products off the market quickly.
"FDA's role is very challenging," says Lushniak, who leads FDA's Office of Counterterrorism and Emerging Threats (OCET). "We need to balance public health needs, regulatory requirements, and science, as we assist with defense of the nation."
Above is an extract from a larger collection of articles and information ad FDA. You can learn more by following the links provided below;
FDA's Counterterrorism Web page
CARVER + Shock